clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Hyperemesis Gravidarum D006939 2 associated lipids
Empyema, Pleural D016724 2 associated lipids
Mastoiditis D008417 2 associated lipids
Pityriasis Rosea D017515 3 associated lipids
Duodenogastric Reflux D004383 2 associated lipids
Tuberculosis, Multidrug-Resistant D018088 6 associated lipids
Scrub Typhus D012612 3 associated lipids
Tuberculosis, Avian D014379 2 associated lipids
Typhoid Fever D014435 2 associated lipids
Central Nervous System Protozoal Infections D020808 3 associated lipids
Tenosynovitis D013717 3 associated lipids
Splenic Diseases D013158 5 associated lipids
Hernia, Hiatal D006551 3 associated lipids
Chlamydial Pneumonia D061387 2 associated lipids
Leprosy, Lepromatous D015440 2 associated lipids
Gastritis, Hypertrophic D005758 1 associated lipids
Hypoproteinemia D007019 1 associated lipids
Cutaneous Fistula D017577 1 associated lipids
Tuberculosis, Ocular D014392 1 associated lipids
Euthyroid Sick Syndromes D005067 1 associated lipids
Parotid Diseases D010305 1 associated lipids
Achlorhydria D000126 1 associated lipids
Eye Infections D015817 1 associated lipids
Buruli Ulcer D054312 1 associated lipids
Leprosy, Paucibacillary D056005 2 associated lipids
Granuloma, Plasma Cell D006104 1 associated lipids
Encephalomyelitis, Acute Disseminated D004673 1 associated lipids
Immune Reconstitution Inflammatory Syndrome D054019 1 associated lipids
Parotid Neoplasms D010307 2 associated lipids
Extensively Drug-Resistant Tuberculosis D054908 1 associated lipids
Upper Extremity Deep Vein Thrombosis D056824 1 associated lipids
Immunoproliferative Small Intestinal Disease D007161 2 associated lipids
Tuberculosis, Spinal D014399 1 associated lipids
Epilepsy, Partial, Motor D020938 1 associated lipids
Empyema, Tuberculous D004654 1 associated lipids
Serositis D012700 1 associated lipids
Glossitis, Benign Migratory D005929 1 associated lipids
Sacroiliitis D058566 1 associated lipids
Pseudomyxoma Peritonei D011553 1 associated lipids
Tooth, Nonvital D019553 2 associated lipids
Myxoma D009232 1 associated lipids
Kleine-Levin Syndrome D017593 1 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Sugano H et al. [Helicobacter pylori eradication therapy for gastric ulcer in elderly]. 2010 Nippon Rinsho pmid:21061532
Shirai T et al. [Four kinds of new triple therapy regiments for Helicobacter pylori eradication in patients with peptic ulcer]. 1999 Nippon Rinsho pmid:10036951
Nakagawa M et al. [A comparative study; one week treatment versus two weeks treatment with lansoprazol, amoxycillin and clarythromycin for the eradication of Helicobacter pylori in patient with gastric and duodenal ulcer]. 1999 Nippon Rinsho pmid:10036952
Kihira K et al. [Triple therapy regimens involving H2 blockaders for therapy of Helicobacter pylori infections]. 1999 Nippon Rinsho pmid:10036953
Kato M [Expanded indication of National Health Insurance for H. pylori associated gastritis]. 2014 Nippon Rinsho pmid:24912302
Nakajima S et al. [Effect of probiotics on the prevention of diarrhea in Helicobacter pylori therapy]. 2005 Nippon Rinsho pmid:16363597
Hikichi T et al. [Influence of cytochrome P450 2C19 genetic polymorphism on H. pylori eradication therapy]. 2005 Nippon Rinsho pmid:16363603
Take S et al. [Influence of interleukin-1beta genetic polymorphism on H. pylori eradication therapy]. 2005 Nippon Rinsho pmid:16363604
Kodama R et al. [Eradication therapy of Helicobacter pylori in gastroduodenal ulcer and its long-term course]. 1993 Nippon Rinsho pmid:8283646
Watanabe T and Chiba T [Clinical features of peptic ulcer disease in the elderly]. 2002 Nippon Rinsho pmid:12187741
Nakamura T and Terano A [Eradication therapy of Helicobacter pylori for elderly patients in Japan]. 2002 Nippon Rinsho pmid:12187752
Iwabuchi H and Matsuzaki K [The treatment of peptic ulcer in elderly CRF patients]. 2002 Nippon Rinsho pmid:12187758
Nagai H [Nontuberculous mycobacteriosis]. 2003 Nippon Rinsho pmid:12722274
Asaka M [Guidelines in the management of Helicobacter pylori infection in Japan]. 2003 Nippon Rinsho pmid:12722304
Inoue K and Sugano K [Eradication therapy for clarithromycin-resistant and metronidazole-resistant Helicobacter pylori infection]. 2002 Nippon Rinsho pmid:11979828
Miwa H et al. [Adverse effects of H. pylori eradication therapy and its measure]. 2002 Nippon Rinsho pmid:11979829
Sakaki N [Acute mucosal lesion of the upper-gastrointestinal tract observed after H. pylori-eradication]. 2002 Nippon Rinsho pmid:11979830
Haruma K et al. [H. pylori eradication therapy and natural history of peptic ulcer]. 2002 Nippon Rinsho pmid:11979833
Sawada A [Gastroduodenal ulcer in childhood]. 2002 Nippon Rinsho pmid:11979854
Watanabe T and Chiba T [Peptic ulcer in the elderly]. 2002 Nippon Rinsho pmid:11979855
Sugano K [Role of proton pump inhibitors in the eradication therapy for Helicobacter pylori (overviews)]. 2002 Nippon Rinsho pmid:11979859
Iwasaki A [Proton pump inhibitors: Omeprazole]. 2002 Nippon Rinsho pmid:11979860
Kawata H and Satoh K [Proton pump inhibitors: Efficacy of lansoprazole in eradicating Helicobacter pylori]. 2002 Nippon Rinsho pmid:11979862
Inoue K et al. [Antimicrobial resistant test of H. pylori]. 2001 Nippon Rinsho pmid:11218400
Murakami K et al. [Selection of antibiotics and planning of eradication for H. pylori infection]. 2001 Nippon Rinsho pmid:11218403
Tanabe H et al. [Usefulness of new triple therapy containing PPI]. 2001 Nippon Rinsho pmid:11218404
Ohkusa T and Watanabe M [A strategy for second-line anti-Helicobacter pylori therapy in patients with previously failed treatment]. 2001 Nippon Rinsho pmid:11218406
Maeda S and Yoshida H [Mechanism of drug resistance in Helicobacter pylori]. 2001 Nippon Rinsho pmid:11218414
Kamiya S [Helicobacter pylori infection and probiotics]. 2007 Nippon Saikingaku Zasshi pmid:17575794
Keto Y et al. [Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils]. 2001 Nippon Yakurigaku Zasshi pmid:11680169
Young A Hold the big MAC. 1996 Notes Undergr pmid:11363450
Pot shots. 1996 Notes Undergr pmid:11363915
Navuluri R and Yue S Understanding peptic ulcer disease pharmacotherapeutics. 1999 Nurse Pract pmid:10100245
Wollner T Eradicate H. pylori with effective treatment regimens. 2004 Nurse Pract pmid:15257123
Holdcroft C Two new macrolide antibiotics: clarithromycin and azithromycin. 1993 Nurse Pract pmid:8380492
Shuster J Clarithromycin and CNS disturbances. 2001 Nursing pmid:11288564
Kiani J and Imam SZ Medicinal importance of grapefruit juice and its interaction with various drugs. 2007 Nutr J pmid:17971226
Bibi Z Role of cytochrome P450 in drug interactions. 2008 Nutr Metab (Lond) pmid:18928560
Bonfigli AR et al. Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. 2016 Nutr Metab Cardiovasc Dis pmid:27480449
Abdullahi M et al. The eradication of Helicobacter pylori is affected by body mass index (BMI). 2008 Obes Surg pmid:18443890
Cerqueira RM et al. Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery--fourteen days superior to seven days? 2011 Obes Surg pmid:20838918
Callen EC and Kessler TL Mycobacterium fortuitum infections associated with laparoscopic gastric banding. 2011 Obes Surg pmid:20336391
Cerqueira RM et al. Cumulative Helicobacter Pylori Eradication Rates by Adopting First- and Second- Line Regimens Proposed by the Maastricht IV Consensus in Obese Patients Undergoing Gastric Bypass Surgery. 2018 Obes Surg pmid:29076008
Cerqueira RM et al. How Effective Is the Quadruple Concomitant Helicobacter Pylori Eradication Therapy for Obese Patients Undergoing Gastric Bypass Surgery? 2016 Obes Surg pmid:26467690
Cerqueira RM et al. Cumulative Helicobacter pylori eradication therapy in obese patients undergoing gastric bypass surgery. 2013 Obes Surg pmid:23054570
Liu DT et al. Stenotrophomonas maltophilia and Mycobacterium chelonae coinfection of the extraocular scleral buckle explant. 2007 Nov-Dec Ocul. Immunol. Inflamm. pmid:18085488
Stewart MW et al. Visual recovery following Mycobacterium chelonae endophthalmitis. 2006 Ocul. Immunol. Inflamm. pmid:16766402
Barros S et al. Cat Scratch Disease: Not a Benign Condition. 2018 Ocul. Immunol. Inflamm. pmid:28665750
Yamauchi Y et al. Conjunctival flora in patients with human immunodeficiency virus infection. 2005 Jul-Aug Ocul. Immunol. Inflamm. pmid:16159721
Madi D et al. Successful treatment of cerebral toxoplasmosis with clindamycin: a case report. 2012 Oman Med J pmid:23074553
Hiyama T et al. c-myc gene mutation in gastric mucosa-associated lymphoid tissue (MALT) lymphoma and diffuse large B-cell lymphoma. 2001 Mar-Apr Oncol. Rep. pmid:11182042
Hiyama T et al. Microsatellite instability at D18S61 is associated with no regression of gastric mucosa-associated lymphoid tissue lymphoma after Helicobacter pylori eradication. 2001 Mar-Apr Oncol. Rep. pmid:11182043
Adachi T et al. Comparative Study of Clarithromycin- versus Metronidazole-Based Triple Therapy as First-Line Eradication for Helicobacter pylori. 2017 Oncology pmid:29258111
Clarithromycin effectively treats infection in AIDS patients. 1993 Oncology (Williston Park, N.Y.) pmid:8512782
Feeney ER and Mallon PW HIV and HAART-Associated Dyslipidemia. 2011 Open Cardiovasc Med J pmid:21643501
Lee C et al. A patient with shortness of breath and bilateral pulmonary infiltrates. 2010 Open Med pmid:21687339
Eber E Treatment of acute viral bronchiolitis. 2011 Open Microbiol J pmid:22262989
Abdalla Abbas M et al. Microbial risk factors of cardiovascular and cerebrovascular diseases: potential therapeutical options. 2008 Open Neurol J pmid:19018303
Mc Laughlin AM et al. Extensively drug-resistant tuberculosis (XDR-TB) - a potential threat in Ireland. 2007 Open Respir Med J pmid:19340317
Fortún J et al. Ca-125: a useful marker to distinguish pulmonary tuberculosis from other pulmonary infections. 2009 Open Respir Med J pmid:19966922
Omurzakova NA et al. Prevalence of Group A b-Hemolytic Streptococcus Among Children with Tonsillopharyngitis in Kyrgyzstan: The Difficulty of Diagnostics and Therapy. 2010 Open Rheumatol J pmid:21253454
Mauriello JA Atypical mycobacterial infection of the periocular region after periocular and facial surgery. 2003 Ophthalmic Plast Reconstr Surg pmid:12918551
Auw-Hädrich C et al. [Clarithromycin for monotherapy of B-cell MALT lymphoma?]. 2013 Ophthalmologe pmid:24231914
Haas K [Reply]. 2013 Ophthalmologe pmid:24377112
Danilko L et al. [Clarithromycin therapy of a B cell MALT lymphoma]. 2013 Ophthalmologe pmid:23224128
Holzer MP et al. [Diagnosis and treatment of mycobacterial keratitis following LASIK. Case report and review of the literature]. 2003 Ophthalmologe pmid:12920556
Krasny J et al. The Relationship between chlamydia trachomatis and chlamydia pneumoniae as the cause of neonatal conjunctivitis (ophthalmia neonatorum). 2005 Jul-Aug Ophthalmologica pmid:16088243
Freitas D et al. An outbreak of Mycobacterium chelonae infection after LASIK. 2003 Ophthalmology pmid:12578767
Solomon A et al. Mycobacterium interface keratitis after laser in situ keratomileusis. 2001 Ophthalmology pmid:11733259
Klapper SR et al. Atypical mycobacterial infection of the orbit. 1995 Ophthalmology pmid:9097803
Klapper SR and Patrinely JR Periocular atypical mycobacterial infections. 1999 Ophthalmology pmid:10485521
Hamam RN et al. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone. 2006 Ophthalmology pmid:16647126
Karia N and Aylward GW Postoperative proprionibacterium acnes endophthalmitis. 2001 Ophthalmology pmid:11297461
Bhagat N et al. Rifabutin-associated hypopyon uveitis in human immunodeficiency virus-negative immunocompetent individuals. 2001 Ophthalmology pmid:11297492
Namiot Z et al. Effect of antibacterial therapy and salivary secretion on the efficacy of Helicobacter pylori eradication in duodenal ulcer patients. 2004 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:15184853
Avcu N et al. The relationship between gastric-oral Helicobacter pylori and oral hygiene in patients with vitamin B12-deficiency anemia. 2001 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:11505263
Lindeboom JA et al. First case of an oculofacial lesion due to Mycobacterium haemophilum infection in an immunocompetent child. 2006 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:16731399
Lindeboom JA et al. Clarithromycin as a single-modality treatment in mycobacterial avium-intracellular infections. 1999 Oral Surg Oral Med Oral Pathol Oral Radiol Endod pmid:9927080
Suzuki H et al. Prognostic factors of chronic rhinosinusitis under long-term low-dose macrolide therapy. 2000 May-Jun ORL J. Otorhinolaryngol. Relat. Spec. pmid:10810255
Luo Q et al. Evaluation of long-term clarithromycin treatment in adult Chinese Patients with chronic rhinosinusitis without nasal polyps. 2011 ORL J. Otorhinolaryngol. Relat. Spec. pmid:21757966
Mazis GA et al. Recurrent fluctuant mass of the wrist and forearm associated with chronic tenosynovitis by Mycobacterium kansasii. 2011 Orthopedics pmid:21598885
Buzás GM and Józan J [Eradication of Helicobacter pylori infection in Europe: a meta-analysis based on congress abstracts, 1997-2002]. 2004 Orv Hetil pmid:15559530
Prónai L and Tulassay Z [Failure of Helicobacter pylori eradication--suggestions for further therapy]. 2003 Orv Hetil pmid:12894674
Buzás GM [Helicobacter pylori -- 2010]. 2010 Orv Hetil pmid:21106480
Buzás GM et al. [The epidemiology of clarithromycin resistance of Helicobacter pylori infection in Hungary]. 2007 Orv Hetil pmid:17656336
Herszényi L [Eradication of Helicobacter pylori]. 2003 Orv Hetil pmid:14626641
Szántó D et al. [Could Helicobacter pylori cause reactive arthro-osteitis?]. 1997 Orv Hetil pmid:9340585
Hagymási K and Tulassay Z [The new aspects of the eradication of Helicobacter pylori and the importance of bacterial resistance]. 2008 Orv Hetil pmid:18926961
Buzás GM [Helicobacter pylori - 2012]. 2012 Orv Hetil pmid:22951408
Buzás György M et al. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. 2000 Orv Hetil pmid:10976194
Buzás GM [The effect of Helicobacter pylori eradication on prokinetic treatment on the quality of life in functional dyspepsia]. 2004 Orv Hetil pmid:15566071
Lengyel G and Zsolt T [Failure in the eradication of Helicobacter pylori: the role of antibiotic resistance]. 2005 Orv Hetil pmid:15926629
Bózsik BP [Comment on Borrelia burgdorferi Group infections]. 2002 Orv Hetil pmid:12073543
Cervin A et al. One-year low-dose erythromycin treatment of persistent chronic sinusitis after sinus surgery: clinical outcome and effects on mucociliary parameters and nasal nitric oxide. 2002 Otolaryngol Head Neck Surg pmid:12075221
Fraser L et al. Atypical mycobacterial infection of the head and neck in children: a 5-year retrospective review. 2008 Otolaryngol Head Neck Surg pmid:18312877
Tatar EÇ et al. Prevalence of biofilms and their response to medical treatment in chronic rhinosinusitis without polyps. 2012 Otolaryngol Head Neck Surg pmid:22241786
Hassmann-Poznańska E et al. [Efficacy of clarithromycin (Fromilid) in treatment of uncomplicated acute bacterial rhinosinusitis in children]. 2003 Otolaryngol Pol pmid:15049183
Denys A [Theoretical basis for the antibiotic therapy of the upper part of the respiratory system]. 1997 Otolaryngol Pol pmid:9757681
Kubas G and Gospodarek T [The use of clarithromycin and amoxycillin in pediatric acute otitis media]. 1997 Otolaryngol Pol pmid:9757683
Hayashi Y et al. Torsades de pointes ventricular tachycardia induced by clarithromycin and disopyramide in the presence of hypokalemia. 1999 Pacing Clin Electrophysiol pmid:10234723